CLYM vs MBX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CLYM

29.1
AI Score
VS
MBX Wins

MBX

35.7
AI Score

Investment Advisor Scores

CLYM

29score
Recommendation
AVOID NEW MONEY

MBX

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CLYM MBX Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 29.1/100 35.7/100 MBX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

CLYM 1M: +18.8% · 3M: -16.8% MBX 1M: +17.8% · 3M: -14.0%

Current Technical Phase

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.2 · Price: $12.25

MBX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.2 · Price: $57.72

Fundamentals Snapshot

Metric CLYM MBX
Market Cap — —
Forward P/E -12.3 -13.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.81 -2.47
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MBX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.